EPCA：早期前列腺癌检测的新指标
摘要
前列腺癌是男性常见的恶性肿瘤。一种新近发现的前列腺癌生物标志物EPCA（Early Pmstate Cancer Antigen）豆示出良好的特异性和灵敏度。现对该分子标志物的研究现状作一综述。
出处
《国际泌尿系统杂志》
2008年第3期309-311,共3页
International Journal of Urology and Nephrology
参考文献14
-
1Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with aprostate - specific antigen level < or = 4.0 ng permilliliter. N Engl J Med,2004,350:2239 -2246.
-
2Shariat SF, Karam JA, Roehrborn CG, et al. Blood biomarkers for prostate cancer detection and prognosis. Future Oncology, 2007, 3 (4) :449 -461.
-
3Troyer D. Emerging biomarkers in prostate cancer. Aging Health, 2006 ,2(4) :579 -588.
-
4Leman ES, Getzenberg RH. Nuclear structure as a source of cancer specific biomarkers. J Cell Biochem. 2007 ( Published Online: 23 Apt 2007 ).
-
5Bradford TJ, Tomlins SB, Wang X, et al. Molecular markers of prostate cancer. Urologic Oncology, 2006 (24) : 538 - 551.
-
6Partin AW, Brawer MK, Bartsch G, et al, Complexed prostate antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial. J Urol,2003,170(5 ) :1787 - 1791.
-
7Wang X, Yu J, Sreekumar A, et al. Autoantibody signatures in prostate cancer, N Engl J Med ,2005,353(12) :1224 -1235.
-
8Getzenberg RH, Pienta K J, Huang EY , et al. Identification of nuclear matrix proteins in the cancer and normal rat prostate. Cancer Res , 1991,51 (24) :6514 -6520.
-
9Leman ES, Arlotti JA, Dhir R, et al, Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer. J Cell Biochem 2002 ; 86 ( 2 ) :203 - 212.
-
10Lakshmanan Y, Subong EN, Partin AW, Differential nuclear matrix protein expression in prostate cancers: correlation with pathologic stage. J Urol ,1998,159(4):1354 - 1358.
-
1毛建英,冯建中,盛陈卓娅,潘建强,平金良,马志红.上皮细胞黏附分子在非小细胞肺癌组织中表达及其临床意义[J].中华实验外科杂志,2016,33(11):2576-2579. 被引量：4
-
2王梅,孟华.联合检测CEA、CA724对胃癌的临床意义[J].中国误诊学杂志,2011,11(1):54-55. 被引量：3
-
3王玉芳,段钊.宫颈癌患者血清DcR_3及SCCA水平及临床意义[J].陕西医学杂志,2014,43(9):1240-1241. 被引量：3
-
4杨鹏,王健.前列腺癌肿瘤标志物应用的研究进展[J].现代医药卫生,2012,28(8):1200-1202. 被引量：1
-
5周绍明,马赟,龚颖平,李青春,崔毅,李博,吴湘,唐双玲.血清CA125检测结合CT对卵巢肿瘤的诊断价值[J].医学临床研究,2009,26(12):2257-2258. 被引量：1
-
6毛红丽,王清霞,尹惠卿.肝癌患者血清中AFP、CYFRA21-1和CA19-9水平检测及意义[J].中国误诊学杂志,2009,9(28):6890-6891.
-
7于跃,武美.前列腺癌抗原标志物的研究进展[J].实用中西医结合临床,2013,13(4):92-94. 被引量：1
-
8乐凌云,田炳如,夏永明,王明.糖类肿瘤相关抗原检测对多发性骨髓瘤诊断价值[J].中国基层医药,2013,20(12):1866-1867. 被引量：2
-
9熊樱,梁立治,郑敏,魏梅,沈扬.鳞状细胞癌抗原与子宫颈鳞状细胞癌的临床病理特征及预后的关系[J].中华妇产科杂志,2007,42(1):29-33. 被引量：36
-
10戴雨,戴大江,刘京旋,杨航燕.CA_(125)、CA_(199)、CEA在肺癌、消化系统肿瘤测定的临床意义[J].空军总医院学报,2001,17(2):94-95. 被引量：5
